Almac Group, a UK-based contract development and manufacturing company, has unveiled a unified clinical trial supply solution to improve experience for sponsors.

Dubbed Almac ONE, the new platform is intended to offer a responsive end-to-end process that could align the digital and physical clinical supply chain, in turn providing enhanced visibility and accuracy throughout a trial’s lifecycle.

Clinical supply chain involves variable recruitment patterns and patient demand that lead to disconnect, increased costs and missed milestones across the study.

Almac Group noted that this type of fragmented process affects the alignment of important trial data that is required to make informed and timely decisions.

To address such challenges and optimise the clinical trial supply chain for sponsors, the company developed the Almac ONE solution with experts from the clinical packaging, logistics and IRT spectrum.

The solution delivers a single set of processes and closed-loop technology to enable management of data end-to-end.

It is designed to offer better supply chain visibility and control throughout the lifecycle of a study by aligning patient recruitment, clinical supply and IRT strategies into an optimised data flow.

Almac Clinical Technologies president and managing director Val Higgins said: “We understand that our clients conducting complex and global clinical studies are facing increased pressures on time, delivery and agility.

“In response to these challenges, I am delighted that Almac ONE will provide sponsors with a more streamlined approach to the global supply chain and empowers our clients to make speedier, more accurate decisions to manage their studies.”

The company noted that it is also working towards providing additional solutions for addressing clinical supply chain challenges in the future.